Skip to main content
Equibles

MORGAN STANLEY

Position in CAPR — Capricor Therapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to CAPR Full portfolio

Position in CAPR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$16,483,118
+$3,599,024 QoQ
Shares Held
684,515
+61.5% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 170 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 81% Shared 0% None 19%

Common Shares in CAPR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. CAPR ranks #114 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in CAPR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,483,118 684,515
2026-03-31 $12,884,094 423,819
2025-12-31 $16,907,339 585,840
2025-09-30 $3,977,710 551,694
2025-06-30 $5,467,267 550,581
2025-03-31 $7,737,810 815,365
2024-12-31 $8,718,203 631,754
2024-09-30 $2,000,356 131,516
2024-06-30 $377,758 79,195
2024-03-31 $757,742 111,597
2023-12-31 $233,193 47,688
2023-09-30 $145,992 42,688
2023-06-30 $253,970 53,132
2023-03-31 $181,450 42,998
2022-12-31 $164,636 42,652
2022-09-30 $238,212 39,702
2022-06-30 $132,208 37,882
2022-03-31 $115,744 33,745
2021-12-31 $97,307 33,211
2021-09-30 $203,664 50,663
2021-06-30 $228,028 44,450
2021-03-31 $142,506 30,450
2020-12-31 $190,732 55,607
2020-09-30 $235,425 44,843
2020-06-30 $163,166 35,471
2020-03-31 $2,070 1,725